P009: Improved Overall Survival with First-Line Brentuximab Vedotin plus Chemotherapy in Patients with Advanced Stage III/IV Classical Hodgkin Lymphoma: An Updated Analysis of ECHELON-1

Detalles Bibliográficos
Autores principales: Hutchings, Martin, Ansell, Stephen M., Connors, Joseph M., Kim, Won Seog, Gallamini, Andrea, Ramchandren, Radhakrishnan, Friedberg, Jonathan W., Advani, Ranjana, Evens, Andrew M., Smolewski, Piotr, Savage, Kerry J., Bartlett, Nancy L., Eom, Hyeon-Seok, Abramson, Jeremy S., Dong, Cassie, Campana, Frank, Fenton, Keenan, Puhlmann, Markus, Straus, David J., Radford, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Advanced Stages
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9621481/
http://dx.doi.org/10.1097/01.HS9.0000890604.66330.a0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9621481/
http://dx.doi.org/10.1097/01.HS9.0000890604.66330.a0

Ejemplares similares